Highlights
- •To describe the future challenges of lung SBRT planning.
- •To analyze the features to be accounted for performing the best planning solution.
- •To show the technological solutions for treating it in a safety way.
Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Physica Medica: European Journal of Medical PhysicsReferences
- Optimizing dose prescription in stereotactic body radiotherapy for lung tumors using Monte Carlo dose calculation.Radiother Oncol. 2010; 94: 42-46
International Commission on Radiation Units and Measurements. ICRU Report 62: Prescribing, recording, and reporting photon beam therapy (Supplement to ICRU Report 50); 1999.
- Prescribing, recording, and reporting photon-beam intensity modulated radiation therapy (IMRT).J ICRU. 2010; 10: 1-10
- Stereotactic body radiation therapy: the report of AAPM Task Group 101.Med Phys. 2010; 37: 4078-4101
- Lung stereotactic ablative body radiotherapy: a large scale multi-institutional planning comparison for interpreting results of multi-institutional studies.Phys Med. 2016; 32: 600-606
- Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: japan clinical oncology group study JCOG0403.Int J Radiat Oncol Biol Phys. 2015; 93: 989-996
- Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial.Int J Radiat Oncol Biol Phys. 2011; 80: 1343-1349
- A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer.Radiother Oncol. 2007; 85: 429-434
- Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.J Clin Oncol. 2009; 27: 3290-3296
- Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT – the Nordic experience.Acta Oncol. 2015; 54: 1096-1104
- Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.Int J Radiat Oncol Biol Phys. 2009; 75: 677-682
- Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.Lung Cancer. 2010; 68: 72-77
- Stereotactic body radiation therapy for inoperable early stage lung cancer.J Am Med Assoc. 2010; 303: 1070-1076
- Efficacy and toxicity analysis of NRG oncology/RTOG 0813 trial of stereotactic body radiation therapy (SBRT) for centrally located non-small cell lung cancer (NSCLC).Int J Radiat Oncol Biol Phys. 2015; 90: S30
EORTC 22113 – LungTechTrial, Available at: <https://clinicaltrials.gov> Identifier: NCT01795521.
UK SABR Consortium Stereotactic ablative body radiotherapy (SABR): a resource. Version 5.0, January 2015. Available at: <http://www.actionradiotherapy.org/wp-content/uploads/2014/05/UKSABR Consortium Guidellinesv 41.pdf>; 2015.
- Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan clinical oncology group study JCOG0403.Int J Radiat Oncol Biol Phys. 2015; 93: 989-996
- Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume.J Radiat Res. 2014; : rru037
- Optimization of leaf margins for lung stereotactic body radiotherapy using a flattening filter-free beam.Med Phys. 2015; 42: 2125-2131
- Comparison of pencil beam–based homogeneous vs inhomogeneous target dose planning for stereotactic body radiotherapy of peripheral lung tumors through Monte Carlo-based recalculation.Med Dos. 2015; 40: 248-255
- Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy.Pract Radiat Oncol. 2012; 2: 46-53
- Four-dimensional treatment planning for stereotactic body radiotherapy.Int J Radiat Oncol Biol Phys. 2007; 69: 276-285
- Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: conventional vs robotic linac.Med Phys. 2013; 40: 051705
- A Feasibility dosimetric study on prostate cancer: are we ready for a multicenter clinical trial on SBRT?.Strahlenther Onkol. 2015; 191: 573-581
- Multicentre treatment planning inter-comparison in a national context: the liver stereotactic ablative radiotherapy case.Phys Med. 2016; 32: 277-283
- Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique.Radiat Oncol. 2011; 9: 152
- Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.Radiother Oncol. 2010; 97: 437-442
- A dosimetric comparison of stereotactic body radiation therapy techniques for lung cancer: robotic versus conventional linac-based systems.J Appl Clin Med Phys. 2010; 11: 3223
- Dosimetric evaluation of four-dimensional dose distributions of CyberKnife and volumetric-modulated arc radiotherapy in stereotactic body lung radiotherapy.J Appl Clin Med Phys. 2013; 14: 4229
- Lung SBRT: dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMRT.J Appl Clin Med Phys. 2013; 14: 4065
- A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer.Med Dosim. 2016; 41: 87-91
- Conformality study for stereotactic radiosurgery of the lung.Med Dosim. 2011; 36: 14-20
- Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques.Int J Radiat Oncol Biol Phys. 2011; 80: 506-513
- Acute Skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who’s at risk?.Int J Radiat Oncol Biol Phys. 2008; 72: 1283-1286
- Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: a dosimetric and treatment efficiency analysis.Radiother Oncol. 2010; 95: 153-157
- Optimising stereotactic body radiotherapy for non-small cell lung cancer with volumetric intensity-modulated arc therapy a planning study.Clin Oncol. 2012; 24: 68-75
- A dosimetric evaluation of VMAT for the treatment of non-small cell lung cancer.J Appl Clin Med Phys. 2013; 14: 228-238
- Volumetric modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques.Int J Radiat Oncol Biol Phys. 2011; 81: 1560-1567
- The effect of beam arrangements and the impact of non-coplanar beams on the treatment planning of stereotactic ablative radiation therapy for early stage lung cancer.J Med Radiat Sci. 2016; 63: 31-40
- 4π Noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.Int J Radiat Oncol Biol Phys. 2013; 86: 407-413
- Integral dose investigation of noncoplanar treatment beam geometries in radiotherapy.Med Phys. 2014; 41: 011905
- Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity modulated arcs.Radiot Oncol. 2009; 93: 122-124
- A treatment-planning comparison of three beam arrangement strategies for stereotactic body radiation therapy for centrally located lung tumors using volumetric-modulated arc therapy.J Radiat Res. 2016; 57: 273-279
- Circumferential or sectored beam arrangements for stereotactic body radiation therapy (SBRT) of primary lung tumors: effect on target and normal structure dose-volume metrics.Med Dosim. 2013; 8: 407-412
- Dosimetric comparison of two arc-based stereotactic body radiotherapy techniques for early-stage lung cancer.Med Dosim. 2015; 40: 76-81
- Optimal dose and fraction number in SBRT of lung tumours: a radiobiological analysis.Phys Med. 2017; 44: 188-195https://doi.org/10.1016/j.ejmp.2016.12.012
- Evaluation of a commercial biologically based IMRT treatment planning system.Med Phys. 2008; 35: 5851-5860
- Improved critical structure sparing with biologically based IMRT optimization.Med Phys. 2009; 36: 1790-1799
- The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM.Med Phys. 2012; 39: 1386-1409
- Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.Phys Med Biol. 2008; 53: 6345-6362
- Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy.Med Phys. 2012; 39: 237-245
- Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimization technique.Int J Radiat Oncol Biol Phys. 2005; 63: 179-187
- Application of constrained optimization to radiotherapy planning.Med Phys. 1999; 26: 2359-2366
- Normal tissue dose-effect models in biological dose optimisation.Z Med Phys. 2008; 18: 102-110
- On the pre-clinical validation of a commercial model-based optimisation engine: application to volumetric modulated arc therapy for patients with lung or prostate cancer.Radiother Oncol. 2014; 113: 385-391
- Multicriteria optimization for volumetric-modulated arc therapy by decomposition into afluence-based relaxation and a segment weight-based restriction.Med Phys. 2012; 39: 6712-6725
- Optimization of stereotactic body radiotherapy treatment planning using a multicriteria optimization algorithm.Z Med Phys. 2016; ([pii: S0939-3889(16)30004-6])
- Automated planning for lung SBRT: faster optimization without compromise on plan quality.Radiot Oncol. 2015; 115: S593-S594
- Volumetric-modulated arc therapy planning using multicriteria optimization for localized prostate cancer.J Appl Clin Med Phys. 2015; 16: 5410
- Multi-criteria optimization methods in radiation therapy planning: a review of technologies and directions.in: Operations research in healthcare. Springer-Verlag, Berlin2015
- IMRT dose shaping with regionally variable penalty scheme.Med Phys. 2003; 30: 544-551
- Predicting dose-volume histograms for organs-at-risk in IMRT planning.Med Phys. 2012; 39: 7446-7461
- Can knowledge-based DVH predictions be used for automated, in dividualized quality assurance of radiotherapy treatment plans?.Radiat Oncol. 2015; 10: 234
- ICycle: Integrated, multicriterial beam angle, and profile optimization for generation of coplanar and noncoplanar IMRT plans.Med Phys. 2012; 39: 951-963
Aspradakis MM, Byene JP, Palmans H, Conway J, Rosser K, Warrington AP et al. Small field MV photon dosimetry. IPEM Report 103. York, UK; 2010.
- Properties of a commercial PTW-60019 synthetic diamond detector for the dosimetry of small radiotherapy beams.Phys Med Biol. 2015; 60: 905-924
- Small field output factors evaluation with a microDiamond detector over 30 Italian centers.Phys Med. 2016; 32: 1644-1650
- CyberKnife beam output factor measurements: a multi-site and multi-detector study.Phys Med. 2016; 32: 1637-1643
- Dosimetric performance and array assessment of plastic scintillation detectors for stereotactic radiosurgery quality assurance.Med Phys. 2012; 39: 429-436
- Validation of a prototype DiodeAir for small field dosimetry.Phys Med Biol. 2015; 60: 2939-2953
- A new formalism for reference dosimetry of small and nonstandard fields.Med Phys. 2008; 35: 5179-5186
- Detector to detector corrections: a comprehensive experimental study of detector specific correction factors for beam output measurements for small radiotherapy beams.Med Phys. 2014; 41: 072103-72116
- Small field detector correction factors kQclin, Qmsrfclin, fmsr for silicon-diode and diamond detectors with circular 6 MV fields derived using both empirical and numerical methods.Med Phys. 2016; 43: 411-423
- Variation of kQclin, Qmsr (fclin, fmsr) for the small-field dosimetric parameters percentage depth dose, tissue-maximum ratio, and off-axis ratio.Med Phys. 2014; 41: 101708
- Can small field diode correction factors be applied universally?.Radiother Oncol. 2014; 112: 442-446
- Monte Carlo simulated corrections for beam commissioning measurements with circular and MLC shaped fields on the CyberKnife M6 System: a study including diode, microchamber, point scintillator, and synthetic microdiamond detectors.Phys Med Biol. 2017; 62: 1076-1095
- Quality assurance device for four-dimensional IMRT or SBRT and respiratory gating using patient-specific intrafraction motion kernels.J Appl Clin Med Phys. 2007; 8: 152
- Commissioning and verification of the collapsed cone convolution superposition algorithm for SBRT delivery using flattening filter-free beams.J Appl Clin Med Phys. 2014; 15: 39
- Comparing measurement-derived (3DVH) and machine log file-derived dose reconstruction methods for VMAT QA in patient geometries.J Appl Clin Med Phys. 2014; 15: 4645
- The sensitivity of gamma-index method to the positioning errors of high-definition MLC in patient-specific VMAT QA for SBRT.Radiat Oncol. 2014; 28: 167
- Commissioning Monte Carlo algorithm for robotic radiosurgery using cylindrical 3D-array with variable density inserts.Physica Med. 2017; 33: 152-158
- Treating patients with Dynamic Wave Arc: First clinical experience.Radiother Oncol. 2017; ([pii: S0167-8140(17)30011-7])
- High resolution ion chamber array delivery quality assurance for robotic radiosurgery: commissioning and validation.Phys Med. 2016; 32: 838-846
- IMRT commissioning: Multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119.Med Phys. 2009; 36: 5359-5373
- Gamma index comparison of three VMAT QA systems and evaluation of their sensitivity to delivery errors.Phys Med. 2015; 31: 720-725
- A study on the correlation between plan complexity and gamma index analysis in patient specific quality assurance of volumetric modulated arc therapy.Rep Pract Oncol Radiother. 2015; 20: 57-65
- Influence of segment width on plan quality for volumetric modulated arc based stereotactic body radiotherapy.Rep Pract Oncol Radiother. 2014; 19: 287-295
- Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.J Appl Clin Med Phys. 2014; 16: 5128
- VMAT QA: measurement-guided 4D dose reconstruction on a patient.Med Phys. 2012; 39: 4228-4238
- Selective robust optimization: a new intensity-modulated proton therapy optimization strategy.Med Phys. 2015; 42: 4840-4847
- SBRT for prostate cancer: challenges and features from a physicist prospective.Phys Med. 2016; 32: 479-484